LATE PULMONARY TOXICITY ASSOCIATED WITH EVEROLIMUS IN A RENAL TRANSPLANT PATIENT AND REVIEW OF THE LITERATURE

ARZU VELİOGLU, EMEL ERYUKSEL, CAGATAY CİMSİT, SERHAN TUGLULAR, CETİN OZENER

Experimental and Clinical Transplantation - 2018;16(4):491-494

The use of inhibitors of mammalian target of rapamycin is associated with adverse pulmonary effects. Although sirolimus-related pneumonitis has been well described, reports on pneumonitis with everolimus are scarce. We report a case of everolimusinduced pneumonitis in a renal transplant recipient 5 years after initiation of everolimus treatment, and we also review the literature regarding everolimus-induced pneumonitis in renal transplant patients.